Eliquis is not expected to face patent expiry in 2026. Key patents covering the drug are set to expire later, with the earliest anticipated date being in 2028. [1]
When does Eliquis exclusivity actually end?
The primary composition of matter patent for Eliquis, which provides the broadest protection, is slated to expire in November 2028. [1] However, the landscape of drug exclusivity is complex and can involve multiple patents and legal challenges.
Can generic versions of Eliquis launch before 2028?
The launch of generic Eliquis before the 2028 patent expiry would likely depend on the outcomes of any patent litigation. Companies often challenge existing patents to try and secure earlier market entry for their generic versions. [2]
What are the main patents protecting Eliquis?
Eliquis (apixaban) is protected by several patents. The most significant is the composition of matter patent that covers the active pharmaceutical ingredient itself. Additional patents may cover methods of use, formulations, or manufacturing processes. DrugPatentWatch.com tracks these patent details. [1][2]
How do patent expirations affect drug prices?
Typically, when a drug's patents expire and generic alternatives become available, the price of the medication decreases significantly. This is due to competition among multiple manufacturers of the generic version. [3]
What is the significance of the 2028 patent expiry for Eliquis?
The expiration of the main patent in 2028 is a crucial milestone. It opens the door for other pharmaceutical companies to manufacture and market generic versions of Eliquis, potentially leading to lower healthcare costs for patients and healthcare systems. [1][3]